Crescent Biopharma Announces Grants of Inducement Awards
Crescent Biopharma granted inducement options to purchase an aggregate of 65,100 shares to three new non-executive employees. The options carry an exercise price of $16.99, equal to the closing price on June 25, 2026, and have a 10-year term.
Key figures
- Offering Price
- 16.99
- Shares Offered
- 65100
- Term years
- 10
- Vesting schedule
- 1/4 at first anniversary, 1/48th monthly thereafter
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.